These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23563012)

  • 21. Use of International Classification of Diseases, Ninth Revision, Clinical Modification codes and medication use data to identify nosocomial Clostridium difficile infection.
    Schmiedeskamp M; Harpe S; Polk R; Oinonen M; Pakyz A
    Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1070-6. PubMed ID: 19803724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clostridium difficile: trend in an Italian Tertiary Care Hospital during fifteen years, 2002-2016.
    Masucci L; Nicolotti N; Graffeo R; Tamburrano A; Archibusacci CM; Nagel D; Quaranta G; Eisendle K; Primus S; Romano L; Mazzella P; Posteraro B; Cammarota G; Sanguinetti M
    Minerva Med; 2019 Apr; 110(2):168-171. PubMed ID: 30821431
    [No Abstract]   [Full Text] [Related]  

  • 23. Emergence of Clostridium difficile infection in tuberculosis patients due to a highly rifampicin-resistant PCR ribotype 046 clone in Poland.
    Obuch-Woszczatyński P; Dubiel G; Harmanus C; Kuijper E; Duda U; Wultańska D; van Belkum A; Pituch H
    Eur J Clin Microbiol Infect Dis; 2013 Aug; 32(8):1027-30. PubMed ID: 23443474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin.
    Figueroa I; Johnson S; Sambol SP; Goldstein EJ; Citron DM; Gerding DN
    Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S104-9. PubMed ID: 22752857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in treatment of community-onset Clostridioides difficile infection after release of updated guidelines, Atlanta, Georgia, 2018.
    Adelman MW; Goodenough D; Sefton S; Mackey C; Thomas S; Fridkin SK; Woodworth MH
    Anaerobe; 2021 Aug; 70():102364. PubMed ID: 33862203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset.
    Kimura T; Snijder R; Sugitani T
    J Infect Chemother; 2019 Aug; 25(8):615-620. PubMed ID: 30987950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular epidemiology of Clostridium difficile strains from nosocomial-acquired infections.
    Corbellini S; Piccinelli G; De Francesco MA; Ravizzola G; Bonfanti C
    Folia Microbiol (Praha); 2014 Mar; 59(2):173-9. PubMed ID: 24081935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clostridium difficile bacteremia.
    Kaufman E; Liska D; Rubinshteyn V; Nandakumar G
    Surg Infect (Larchmt); 2013 Dec; 14(6):559-60. PubMed ID: 24111758
    [No Abstract]   [Full Text] [Related]  

  • 29. Reduction in Clostridium difficile environmental contamination by hospitalized patients treated with fidaxomicin.
    Biswas JS; Patel A; Otter JA; Wade P; Newsholme W; van Kleef E; Goldenberg SD
    J Hosp Infect; 2015 Jul; 90(3):267-70. PubMed ID: 25728208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modified multiple-locus variable-number tandem-repeat analysis for rapid identification and typing of Clostridium difficile during institutional outbreaks.
    Broukhanski G; Low DE; Pillai DR
    J Clin Microbiol; 2011 May; 49(5):1983-6. PubMed ID: 21411590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasmid Acquisition Alters Vancomycin Susceptibility in Clostridioides difficile.
    Pu M; Cho JM; Cunningham SA; Behera GK; Becker S; Amjad T; Greenwood-Quaintance KE; Mendes-Soares H; Jones-Hall Y; Jeraldo PR; Chen J; Dunny G; Patel R; Kashyap PC
    Gastroenterology; 2021 Feb; 160(3):941-945.e8. PubMed ID: 33197449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinico-microbiological analysis of toxigenic clostridium difficile from hospitalised patients in a tertiary care hospital, Mangalore, Karnataka, India.
    Justin S; Antony B
    Indian J Med Microbiol; 2019; 37(2):186-191. PubMed ID: 31745017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of recurrent Clostridium difficile infection: a systematic review.
    O'Horo JC; Jindai K; Kunzer B; Safdar N
    Infection; 2014 Feb; 42(1):43-59. PubMed ID: 23839210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clostridium difficile infection, Colorado and the northwestern United States, 2007.
    Kuntz JL; Johnson ES; Raebel MA; Petrik AF; Yang X; Thorp ML; Spindel SJ; Neil N; Smith DH
    Emerg Infect Dis; 2012 Jun; 18(6):960-2. PubMed ID: 22608207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The emergence of metronidazole and vancomycin reduced susceptibility in Clostridium difficile isolates in Iran.
    Kouhsari E; Douraghi M; Krutova M; Fakhre Yaseri H; Talebi M; Baseri Z; Moqarabzadeh V; Sholeh M; Amirmozafari N
    J Glob Antimicrob Resist; 2019 Sep; 18():28-33. PubMed ID: 30703583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.
    Labbé AC; Poirier L; Maccannell D; Louie T; Savoie M; Béliveau C; Laverdière M; Pépin J
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3180-7. PubMed ID: 18573937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital.
    Babady NE; Stiles J; Ruggiero P; Khosa P; Huang D; Shuptar S; Kamboj M; Kiehn TE
    J Clin Microbiol; 2010 Dec; 48(12):4519-24. PubMed ID: 20943860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
    Bishara J; Wattad M; Paul M
    Clin Infect Dis; 2007 Dec; 45(12):1646-7; author reply 1649-51. PubMed ID: 18190329
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clostridioides difficile infection: various therapeutic approaches].
    Meuwly M; Chuard C
    Rev Med Suisse; 2022 Oct; 18(799):1896-1899. PubMed ID: 36226451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of Oral Vancomycin for Clostridioides difficile Infection and the Risk of Vancomycin-Resistant Enterococci.
    Stevens VW; Khader K; Echevarria K; Nelson RE; Zhang Y; Jones M; Timbrook TT; Samore MH; Rubin MA
    Clin Infect Dis; 2020 Jul; 71(3):645-651. PubMed ID: 31504328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.